Spruce Biosciences, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · South San Francisco, CA
SPRB chart
What traders are saying about $SPRB
Latest postsSpruce Biosciences, Inc. news
- B. Riley Securities Maintains Spruce Biosciences(SPRB.US) With Buy Rating, Maintains Target Price $160
Moomoo ·
- Spruce Biosciences at Guggenheim healthcare conference: FDA path in focus
Investing.com ·
- Spruce Biosciences spins out CAH program into new subsidiary
BioWorld News ·
- Spruce Biosciences, Inc. (SPRB) Stock Price, News, Quote & History
Yahoo! Finance Canada ·
- Spruce Biosciences Posts $24 Million Q3 Loss, $8.51 Per Share
TOKENPOST ·
- Spruce Biosciences Faces Funding Risk as Uncertainty Looms Over TA-ERT FDA Priority Review Voucher and Sale Prospects
TipRanks ·
- Spruce Biosciences 3Q Loss $24M >SPRB
Moomoo ·
- Spruce Bio Spins CAH Program Off into New Subsidiary Adrenyx
Contract Pharma ·
- Form 8K Spruce Biosciences Inc For: 9 November By Investing.com
Investing.com South Africa ·
- Spruce Biosciences Releases Q3 2026 Financial Results
AlphaStreet ·
- Spruce Biosciences plans spinoff of CAH drug program By Investing.com
Investing.com Nigeria ·
- Spruce Biosciences, Inc. reports results for the quarter ended September 30 - Earnings Summary
TradingView ·
Spruce Biosciences, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $0 | $4.9M | $10.1M | $0 |
| Net income | -$39.0M | -$53.0M | -$47.9M | -$46.2M |
| Diluted EPS | $-50.83 | $-96.40 | $-1.24 | $-1.96 |
| Total assets (year end) | $53.0M | $45.2M | $103.9M | $85.6M |
| Cash and equivalents (year end) | $48.9M | $38.8M | $96.3M | $24.5M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Spruce Biosciences, Inc.
- Ticker
- SPRB (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- South San Francisco, CA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1683553
Frequently asked questions
What exchange is Spruce Biosciences, Inc. listed on?
Spruce Biosciences, Inc. trades on the Nasdaq under the ticker symbol SPRB.
What industry is Spruce Biosciences, Inc. in?
Spruce Biosciences, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Spruce Biosciences, Inc. headquartered?
Spruce Biosciences, Inc.'s business address on file with the SEC is in South San Francisco, CA.
When does Spruce Biosciences, Inc.'s fiscal year end?
Spruce Biosciences, Inc.'s fiscal year ends on December 31.
How much revenue did Spruce Biosciences, Inc. report?
Spruce Biosciences, Inc. reported $0 in revenue for calendar year 2025, according to its SEC filings.